Global ß-blockers Market Research Report 2021
Table of Contents1 ß-blockers Market Overview
1.1 Product Overview and Scope of ß-blockers
1.2 ß-blockers Segment by Type
1.2.1 Global ß-blockers Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Nonselective Agents
1.2.3 Selective Agents
1.3 ß-blockers Segment by Application
1.3.1 ß-blockers Sales Comparison by Application: (2021-2027)
1.3.2 Abnormal Heart Rhythms
1.3.3 Hypertension
1.4 Global ß-blockers Market Size Estimates and Forecasts
1.4.1 Global ß-blockers Revenue 2016-2027
1.4.2 Global ß-blockers Sales 2016-2027
1.4.3 ß-blockers Market Size by Region: 2016 Versus 2021 Versus 2027
2 ß-blockers Market Competition by Manufacturers
2.1 Global ß-blockers Sales Market Share by Manufacturers (2016-2021)
2.2 Global ß-blockers Revenue Market Share by Manufacturers (2016-2021)
2.3 Global ß-blockers Average Price by Manufacturers (2016-2021)
2.4 Manufacturers ß-blockers Manufacturing Sites, Area Served, Product Type
2.5 ß-blockers Market Competitive Situation and Trends
2.5.1 ß-blockers Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest ß-blockers Players Market Share by Revenue
2.5.3 Global ß-blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ß-blockers Retrospective Market Scenario by Region
3.1 Global ß-blockers Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global ß-blockers Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America ß-blockers Market Facts & Figures by Country
3.3.1 North America ß-blockers Sales by Country
3.3.2 North America ß-blockers Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe ß-blockers Market Facts & Figures by Country
3.4.1 Europe ß-blockers Sales by Country
3.4.2 Europe ß-blockers Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific ß-blockers Market Facts & Figures by Region
3.5.1 Asia Pacific ß-blockers Sales by Region
3.5.2 Asia Pacific ß-blockers Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America ß-blockers Market Facts & Figures by Country
3.6.1 Latin America ß-blockers Sales by Country
3.6.2 Latin America ß-blockers Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa ß-blockers Market Facts & Figures by Country
3.7.1 Middle East and Africa ß-blockers Sales by Country
3.7.2 Middle East and Africa ß-blockers Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global ß-blockers Historic Market Analysis by Type
4.1 Global ß-blockers Sales Market Share by Type (2016-2021)
4.2 Global ß-blockers Revenue Market Share by Type (2016-2021)
4.3 Global ß-blockers Price by Type (2016-2021)
5 Global ß-blockers Historic Market Analysis by Application
5.1 Global ß-blockers Sales Market Share by Application (2016-2021)
5.2 Global ß-blockers Revenue Market Share by Application (2016-2021)
5.3 Global ß-blockers Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Astra Zeneca
6.4.1 Astra Zeneca Corporation Information
6.4.2 Astra Zeneca Description and Business Overview
6.4.3 Astra Zeneca ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Astra Zeneca Product Portfolio
6.4.5 Astra Zeneca Recent Developments/Updates
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Corporation Information
6.5.2 Jhonson and Johnson Description and Business Overview
6.5.3 Jhonson and Johnson ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Jhonson and Johnson Product Portfolio
6.5.5 Jhonson and Johnson Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Eli Lilly Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bristol-Myers Squibb Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bayer Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GSK Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Corporation Information
6.11.2 Teva Pharmaceutical ß-blockers Description and Business Overview
6.11.3 Teva Pharmaceutical ß-blockers Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Teva Pharmaceutical Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
7 ß-blockers Manufacturing Cost Analysis
7.1 ß-blockers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of ß-blockers
7.4 ß-blockers Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 ß-blockers Distributors List
8.3 ß-blockers Customers
9 ß-blockers Market Dynamics
9.1 ß-blockers Industry Trends
9.2 ß-blockers Growth Drivers
9.3 ß-blockers Market Challenges
9.4 ß-blockers Market Restraints
10 Global Market Forecast
10.1 ß-blockers Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of ß-blockers by Type (2022-2027)
10.1.2 Global Forecasted Revenue of ß-blockers by Type (2022-2027)
10.2 ß-blockers Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of ß-blockers by Application (2022-2027)
10.2.2 Global Forecasted Revenue of ß-blockers by Application (2022-2027)
10.3 ß-blockers Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of ß-blockers by Region (2022-2027)
10.3.2 Global Forecasted Revenue of ß-blockers by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global ?-blockers Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global ?-blockers Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global ?-blockers Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers ?-blockers Covered in This Study
Table 5. Global ?-blockers Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global ?-blockers Sales Share by Manufacturers (2016-2021)
Table 7. Global ?-blockers Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global ?-blockers Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market ?-blockers Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers ?-blockers Manufacturing Sites and Area Served
Table 11. Manufacturers ?-blockers Product Type
Table 12. Global ?-blockers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global ?-blockers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ?-blockers as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global ?-blockers Sales by Region (2016-2021) & (K Units)
Table 16. Global ?-blockers Sales Market Share by Region (2016-2021)
Table 17. Global ?-blockers Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America ?-blockers Sales by Country (2016-2021) & (K Units)
Table 19. North America ?-blockers Sales Market Share by Country (2016-2021)
Table 20. North America ?-blockers Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America ?-blockers Revenue Market Share by Country (2016-2021)
Table 22. Europe ?-blockers Sales by Country (2016-2021) & (K Units)
Table 23. Europe ?-blockers Sales Market Share by Country (2016-2021)
Table 24. Europe ?-blockers Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe ?-blockers Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific ?-blockers Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific ?-blockers Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific ?-blockers Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific ?-blockers Revenue Market Share by Region (2016-2021)
Table 30. Latin America ?-blockers Sales by Country (2016-2021) & (K Units)
Table 31. Latin America ?-blockers Sales Market Share by Country (2016-2021)
Table 32. Latin America ?-blockers Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America ?-blockers Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa ?-blockers Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa ?-blockers Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa ?-blockers Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa ?-blockers Revenue Market Share by Country (2016-2021)
Table 38. Global ?-blockers Sales (K Units) by Type (2016-2021)
Table 39. Global ?-blockers Sales Market Share by Type (2016-2021)
Table 40. Global ?-blockers Revenue (Million US$) by Type (2016-2021)
Table 41. Global ?-blockers Revenue Share by Type (2016-2021)
Table 42. Global ?-blockers Price (USD/Unit) by Type (2016-2021)
Table 43. Global ?-blockers Sales (K Units) by Application (2016-2021)
Table 44. Global ?-blockers Sales Market Share by Application (2016-2021)
Table 45. Global ?-blockers Revenue (Million US$) by Application (2016-2021)
Table 46. Global ?-blockers Revenue Share by Application (2016-2021)
Table 47. Global ?-blockers Price (USD/Unit) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer ?-blockers Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Novartis ?-blockers Product
Table 57. Novartis Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Merck ?-blockers Product
Table 62. Merck Recent Developments/Updates
Table 63. Astra Zeneca Corporation Information
Table 64. Astra Zeneca Description and Business Overview
Table 65. Astra Zeneca ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Astra Zeneca ?-blockers Product
Table 67. Astra Zeneca Recent Developments/Updates
Table 68. Jhonson and Johnson Corporation Information
Table 69. Jhonson and Johnson Description and Business Overview
Table 70. Jhonson and Johnson ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Jhonson and Johnson ?-blockers Product
Table 72. Jhonson and Johnson Recent Developments/Updates
Table 73. Eli Lilly Corporation Information
Table 74. Eli Lilly Description and Business Overview
Table 75. Eli Lilly ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Eli Lilly ?-blockers Product
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Sanofi Corporation Information
Table 79. Sanofi Description and Business Overview
Table 80. Sanofi ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Sanofi ?-blockers Product
Table 82. Sanofi Recent Developments/Updates
Table 83. Bristol-Myers Squibb Corporation Information
Table 84. Bristol-Myers Squibb Description and Business Overview
Table 85. Bristol-Myers Squibb ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Bristol-Myers Squibb ?-blockers Product
Table 87. Bristol-Myers Squibb Recent Developments/Updates
Table 88. Bayer Corporation Information
Table 89. Bayer Description and Business Overview
Table 90. Bayer ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Bayer ?-blockers Product
Table 92. Bayer Recent Developments/Updates
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. GSK ?-blockers Product
Table 97. GSK Recent Developments/Updates
Table 98. Teva Pharmaceutical Corporation Information
Table 99. Teva Pharmaceutical Description and Business Overview
Table 100. Teva Pharmaceutical ?-blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Teva Pharmaceutical ?-blockers Product
Table 102. Teva Pharmaceutical Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. ?-blockers Distributors List
Table 106. ?-blockers Customers List
Table 107. ?-blockers Market Trends
Table 108. ?-blockers Growth Drivers
Table 109. ?-blockers Market Restraints
Table 110. Global ?-blockers Sales Forecast by Type (2022-2027) & (K Units)
Table 111. Global ?-blockers Sales Market Share Forecast by Type (2022-2027)
Table 112. Global ?-blockers Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global ?-blockers Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global ?-blockers Sales Forecast by Application (2022-2027) & (K Units)
Table 115. Global ?-blockers Sales Market Share Forecast by Application (2022-2027)
Table 116. Global ?-blockers Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global ?-blockers Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global ?-blockers Sales Forecast by Region (2022-2027) & (K Units)
Table 119. Global ?-blockers Sales Market Share Forecast by Region (2022-2027)
Table 120. Global ?-blockers Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global ?-blockers Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of ?-blockers
Figure 2. Global ?-blockers Market Share by Type in 2020 & 2027
Figure 3. Nonselective Agents Product Picture
Figure 4. Selective Agents Product Picture
Figure 5. Global ?-blockers Market Share by Application in 2020 & 2027
Figure 6. Abnormal Heart Rhythms
Figure 7. Hypertension
Figure 8. Global ?-blockers Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global ?-blockers Market Size 2016-2027 (US$ Million)
Figure 10. Global ?-blockers Sales 2016-2027 (K Units)
Figure 11. Global ?-blockers Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. ?-blockers Sales Share by Manufacturers in 2020
Figure 13. Global ?-blockers Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest ?-blockers Players: Market Share by Revenue in 2020
Figure 15. ?-blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global ?-blockers Sales Market Share by Region (2016-2021)
Figure 17. Global ?-blockers Sales Market Share by Region in 2020
Figure 18. Global ?-blockers Revenue Market Share by Region (2016-2021)
Figure 19. Global ?-blockers Revenue Market Share by Region in 2020
Figure 20. U.S. ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E ?-blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of ?-blockers by Type (2016-2021)
Figure 45. Sales Market Share of ?-blockers by Application (2016-2021)
Figure 46. Sales Market Share of ?-blockers by Application in 2020
Figure 47. Revenue Share of ?-blockers by Application (2016-2021)
Figure 48. Revenue Share of ?-blockers by Application in 2020
Figure 49. Manufacturing Cost Structure of ?-blockers
Figure 50. Manufacturing Process Analysis of ?-blockers
Figure 51. ?-blockers Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed